Misoprostol 2.66 µg/g Topical Powder is a finely divided dry formulation designed for external application to the skin. Packaged with a dispensing mechanism, it offers benefits such as moisture absorption, soothing properties, and friction reduction. This formulation is commonly used to treat dermatological conditions such as psoriasis, eczema, and dermatitis, providing relief and promoting skin health as part of skincare routines.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Misoprostol 2.66 µg/g Topical Powder is a finely divided dry formulation designed for external application to the skin. Misoprostol is a synthetic analog of prostaglandin E1 (PGE1), which plays a crucial role in various physiological processes, including inflammation, vasodilation, and tissue repair. By mimicking the effects of natural prostaglandins, Misoprostol can aid in promoting healing and improving blood flow to the affected area.
The topical powder formulation offers benefits such as moisture absorption, soothing properties, and reduction of friction on the skin. This makes it particularly suitable for managing conditions where excess moisture or friction may exacerbate skin issues. The powder can help keep the area dry, reduce discomfort, and provide a protective layer over sensitive or damaged skin.
For patients, Misoprostol 2.66 µg/g Topical Powder may be used as part of a skincare routine to assist in the management of various dermatological conditions as directed by a healthcare provider. Its application may help in soothing irritated skin, promoting healing, and providing relief from discomfort associated with certain skin conditions. It's important to use the medication exactly as prescribed and report any unusual symptoms or side effects to your healthcare provider promptly.
Prescribers may consider Misoprostol 2.66 µg/g Topical Powder for patients who could benefit from the local effects of prostaglandin analogs on the skin. The topical powder formulation allows for targeted delivery of Misoprostol to the affected area, potentially enhancing therapeutic outcomes while minimizing systemic exposure. This can be particularly advantageous in managing localized skin conditions that may respond to the vasodilatory and healing-promoting effects of prostaglandins.
It is important to note that while Misoprostol is well-known for its gastrointestinal and obstetric uses, the topical application for dermatological purposes may be considered off-label. Prescribers should evaluate the current clinical evidence and consider individual patient needs when deciding to incorporate this formulation into a treatment plan. Monitoring for efficacy and any adverse reactions is advised to ensure patient safety.
Potential side effects of Misoprostol topical application may include local skin reactions such as redness, itching, or irritation. Patients should be advised to report any persistent or severe side effects. Caution is advised in patients with known hypersensitivity to Misoprostol or other prostaglandins. As with all medications, the risk-benefit ratio should be assessed prior to prescribing.
If you have any questions, please reach out to us.
Misoprostol 2.66 µg/g Topical Powder is a specialized formulation designed for external application to the skin. It is often used for its moisture absorption, soothing properties, and ability to reduce friction, making it suitable for various dermatological conditions or as part of skincare routines. While topical application generally results in minimal systemic absorption, it is important to consider potential drug interactions, especially for patients who may be using other medications concurrently.
For patients and prescribers, it is crucial to be aware that although the systemic absorption of misoprostol from topical application is low, interactions with other medications cannot be entirely ruled out. Misoprostol is a prostaglandin E1 analog, and its systemic effects, when absorbed, can include uterine contractions and gastrointestinal effects. Therefore, caution is advised when used in conjunction with other medications that may have similar effects or that may alter prostaglandin pathways.
Patients using nonsteroidal anti-inflammatory drugs (NSAIDs) should be monitored closely, as misoprostol is often used to prevent NSAID-induced gastric ulcers. While the topical formulation is unlikely to provide significant systemic protection, prescribers should be aware of the patient's complete medication profile to avoid potential gastrointestinal complications.
Women of childbearing potential should be particularly cautious, as systemic absorption of misoprostol can potentially lead to uterine contractions and pose a risk of miscarriage. It is essential to discuss contraceptive measures and ensure that the patient is not pregnant before initiating treatment with this topical formulation.
Patients with a history of cardiovascular disease should also be monitored, as prostaglandins can influence vascular tone and blood pressure. Although the risk is minimal with topical application, prescribers should consider the patient's cardiovascular status when recommending this formulation.
Additionally, patients using anticoagulants or those with bleeding disorders should be aware that misoprostol can potentially affect platelet aggregation and increase bleeding risk. While the topical route minimizes this risk, it is still important to consider the overall medication regimen and health status of the patient.
As with any medication, it is essential to review the patient's full medication list, including over-the-counter drugs and supplements, to identify any potential interactions. If you have any questions or need further clarification regarding the use of Misoprostol 2.66 µg/g Topical Powder, please reach out to us at Bayview Pharmacy. We are here to assist both patients and prescribers in ensuring safe and appropriate use of this formulation.
```Misoprostol 2.66 µg/g Topical Powder is a specialized formulation designed for external application to the skin. This finely divided dry powder is often packaged in a container equipped with a dispensing mechanism, allowing for precise and convenient application. The primary function of this topical powder is to provide therapeutic benefits for various dermatological conditions, leveraging the unique properties of misoprostol, a synthetic prostaglandin E1 analog.
When applied to the skin, misoprostol in this formulation works by interacting with prostaglandin receptors in the skin tissue. Prostaglandins are lipid compounds that have diverse roles in the body, including the modulation of inflammation and the promotion of healing processes. By mimicking the action of natural prostaglandins, misoprostol can help to reduce inflammation, promote tissue repair, and enhance the skin's natural barrier function. This makes it particularly useful in conditions where inflammation and impaired skin integrity are prominent features.
The powder form of this medication offers several advantages. It is designed to absorb moisture, which can be beneficial in keeping the affected area dry and reducing the risk of bacterial or fungal growth. This is particularly important in conditions where excess moisture can exacerbate symptoms or delay healing. Additionally, the soothing properties of the powder can help to alleviate discomfort and irritation, providing relief to patients with sensitive or inflamed skin.
Furthermore, the powder can reduce friction between skin surfaces or between the skin and clothing, which is advantageous in preventing further irritation or damage to the skin. This is especially beneficial in areas prone to chafing or in patients with mobility issues where skin folds may be present. The ease of application and the non-greasy nature of the powder make it a convenient option for patients, encouraging adherence to treatment regimens.
For prescribers, it is important to consider the specific dermatological condition being treated and the individual patient's needs when recommending Misoprostol 2.66 µg/g Topical Powder. The formulation's ability to modulate inflammation and promote healing can be a valuable component of a comprehensive treatment plan. However, as with any medication, it is essential to monitor the patient's response and adjust the treatment as necessary to achieve optimal outcomes.
If you have any questions about this formulation or its use in treating specific dermatological conditions, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries or concerns you may have.
Misoprostol 2.66 µg/g Topical Powder is used for external application to the skin, offering benefits such as moisture absorption, soothing properties, or reducing friction. It is commonly used for various dermatological conditions or as part of skincare routines.
Apply the powder to clean, dry skin. Use the dispensing mechanism to apply a thin layer to the affected area, ensuring even coverage. Follow any specific instructions provided by your healthcare provider.
While Misoprostol 2.66 µg/g Topical Powder is generally suitable for most skin types, it is always best to consult with a healthcare provider to ensure it is appropriate for your specific skin condition and type.
Some individuals may experience mild skin irritation or allergic reactions. If you notice any adverse effects, discontinue use and consult a healthcare professional.
The frequency of use will depend on the specific condition being treated and the advice of your healthcare provider. Generally, it is applied once or twice daily, but follow the instructions provided by your healthcare professional.
Yes, Misoprostol 2.66 µg/g Topical Powder can typically be used alongside other skincare products. However, it is advisable to consult with a healthcare provider to ensure compatibility and avoid any potential interactions.
The safety of Misoprostol 2.66 µg/g Topical Powder for children should be determined by a healthcare provider. Always consult a healthcare professional before using this product on children.
Store Misoprostol 2.66 µg/g Topical Powder in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If accidental ingestion occurs, seek medical attention immediately. Provide the healthcare professional with information about the product and the amount ingested.
The use of Misoprostol 2.66 µg/g Topical Powder during pregnancy or breastfeeding should be discussed with a healthcare provider. They can provide guidance based on your specific circumstances and health needs.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)